Get started
AstraZeneca PLCAstraZeneca PLCAstraZeneca PLC

AstraZeneca PLC

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsBonds

AZN chart


Full chart

Key facts today


AstraZeneca's Tezspire gained a positive approval recommendation from the EMA for chronic rhinosinusitis with nasal polyps, showing significant improvements in symptoms and reduced surgery needs.
AstraZeneca's Koselugo received a positive EMA recommendation on September 22, 2025, for treating inoperable plexiform neurofibromas in adults, showing a 20% tumor size reduction.
Analyze the impactAnalyze the impact

AZN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪188.33 B‬ CHF
Dividend yield (indicated)
2.16%
Price to earnings Ratio (TTM)
18.35
Basic EPS (TTM)
4.51 CHF
Net income (FY)
‪6.26 B‬ CHF
Revenue (FY)
‪48.08 B‬ CHF
Shares float
‪1.48 B‬
Beta (1Y)
1.02

Employees


Employees (FY)
‪94.3 K‬
Change (1Y)
‪+4.4 K‬ +4.89%
Revenue / Employee (1Y)
‪509.89 K‬ CHF
Net income / Employee (1Y)
‪66.34 K‬ CHF

About AstraZeneca PLC


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Pascal Soriot
Website
astrazeneca.com
Headquarters
Cambridge
Founded
1913
ISIN
GB0009895292
FIGI
BBG007FJNLY7
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

Check out other big names from the same industry as AZN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AZN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AZN highest yielding bonds


US46353AU2
AstraZeneca PLC 4.375% 17-AUG-2048
Yield to maturity
5.27%
Maturity date
Aug 17, 2048
US46353AZ1
AstraZeneca PLC 3.0% 28-MAY-2051
Yield to maturity
5.25%
Maturity date
May 28, 2051
US46353AX6
AstraZeneca PLC 2.125% 06-AUG-2050
Yield to maturity
5.24%
Maturity date
Aug 6, 2050
US46353AM0
AstraZeneca PLC 4.375% 16-NOV-2045
Yield to maturity
5.23%
Maturity date
Nov 16, 2045
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.13%
Maturity date
Sep 18, 2042
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
4.82%
Maturity date
Sep 15, 2037
US46353AL2
AstraZeneca PLC 3.375% 16-NOV-2025
Yield to maturity
4.77%
Maturity date
Nov 16, 2025
A
US4636NAN3
AstraZeneca Finance LLC 5.0% 26-FEB-2034
Yield to maturity
4.50%
Maturity date
Feb 26, 2034
50UC
AstraZeneca PLC 5.75% 13-NOV-2031
Yield to maturity
4.49%
Maturity date
Nov 13, 2031
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.34%
Maturity date
Mar 3, 2033
US46353AV0
AstraZeneca PLC 0.7% 08-APR-2026
Yield to maturity
4.25%
Maturity date
Apr 8, 2026

See all AZN bonds 

Sparks


Curated watchlists where AZN is featured.

See all sparks 

Frequently Asked Questions


The current price of AZN is 81.00 CHF — it hasn't changed in the past 24 hours. Watch AstraZeneca PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange AstraZeneca PLC stocks are traded under the ticker AZN.
We've gathered analysts' opinions on AstraZeneca PLC future price: according to them, AZN price has a max estimate of 193.51 CHF and a min estimate of 115.61 CHF. Watch AZN chart and read a more detailed AstraZeneca PLC stock forecast: see what analysts think of AstraZeneca PLC and suggest that you do with its stocks.
AZN reached its all-time high on Mar 26, 2019 with the price of 85.52 CHF, and its all-time low was 52.70 CHF and was reached on Dec 6, 2016. View more price dynamics on AZN chart.
See other stocks reaching their highest and lowest prices.
AZN stock is 0.00% volatile and has beta coefficient of 1.02. Track AstraZeneca PLC stock price on the chart and check out the list of the most volatile stocks — is AstraZeneca PLC there?
Today AstraZeneca PLC has the market capitalization of ‪187.77 B‬, it has increased by 0.26% over the last week.
Yes, you can track AstraZeneca PLC financials in yearly and quarterly reports right on TradingView.
AstraZeneca PLC is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
AZN earnings for the last quarter are 1.72 CHF per share, whereas the estimation was 1.71 CHF resulting in a 0.44% surprise. The estimated earnings for the next quarter are 1.83 CHF per share. See more details about AstraZeneca PLC earnings.
AstraZeneca PLC revenue for the last quarter amounts to ‪11.47 B‬ CHF, despite the estimated figure of ‪11.19 B‬ CHF. In the next quarter, revenue is expected to reach ‪11.73 B‬ CHF.
AZN net income for the last quarter is ‪2.00 B‬ CHF, while the quarter before that showed ‪2.65 B‬ CHF of net income which accounts for −24.54% change. Track more AstraZeneca PLC financial stats to get the full picture.
AstraZeneca PLC dividend yield was 2.35% in 2024, and payout ratio reached 69.15%. The year before the numbers were 2.15% and 73.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 22, 2025, the company has ‪94.3 K‬ employees. See our rating of the largest employees — is AstraZeneca PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AstraZeneca PLC EBITDA is ‪15.79 B‬ CHF, and current EBITDA margin is 33.02%. See more stats in AstraZeneca PLC financial statements.
Like other stocks, AZN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AstraZeneca PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AstraZeneca PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AstraZeneca PLC stock shows the buy signal. See more of AstraZeneca PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.